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Polyol-combinant saliva stimulants and oral health in Veterans Affairs 
patients-An exploratory study 
An exploratory study investigated 
the root caries incidence in Depart- 
ment of Veterans Affairs patients with 
exposed root surfaces. For a period of 
six to 30 months, the subjects were 
systematically assigned to groups 
which used chewable dragees or 
chewing gums that contained either 
xylitol or sorbitol as bulk sweeteners. 
The mean treatment time was 1.8 
years (standard deviation = 0.8). The 
consumption levels of both polyols 
was up to 8.5 g daily, used typically 
in five episodes during a 16-hour peri- 
od. The subjects were examined 
every six months in connection with 
their standard scheduled visits at the 
Veterans Affairs Medical Center. The 
risk for a root-surface lesion in the 
xylitol group was only 19% of that for 
a surface in the sorbitol group (rela- 
tive risk, 0.19; 95% confidence inter- 
val, 0.06-0.62; p 50,0065). Simul- 
taneous study in periodontal patients 
showed tbat both polyols significantly 
reduced the gingival index scores, 
and slightly (but not significantly) 
reduced the plaque index scores. 
Collectively, both studies suggest 
that frequent daily consumption of 
chewable, saliva-s timula ting products 
containing essentially nonfermentable 
or slowly fermentable dietary carbohy- 
drate sweeteners (xylitol and sor- 
bitol) may have an oral-health-improv- 
ing effect in Department of Veterans 
Affairs Medical Center patients. It is 
necessary to evaluate if these proce- 
dures would be efficacious in larger 
and expanded patient cohorts. 
esident patients and outpa- 
tients of Department of R Veterans Affairs Medical 
Centers constitute a special focus for 
nursing care from an oral health per- 
spective. Among the most important 
oral health problems of this cohort 
are root-surface caries (RSC) and 
periodontal infections, which con- 
sume substantial health care 
resources and cause suffering, pain, 
and loss of esthetics. Several 
researchers have emphasized the 
increasing impact RSC has on the 
adult and geriatric population in gen- 
eral, especially since the means to 
treat and prevent this disease are lim- 
itedlF5 and because dental treatment 
in compromised patients in general 
must consider complicating issues 
related to patients’ medical 
 problem^.^,^ These efforts will be 
aggravated if the effectiveness of 
antimicrobial functions of oral secre- 
tions declines.8 In addition, the same 
concerns affect the prevention and 
treatment of periodontal infections in 
those patients. 
Several studies have shown that 
xylitol, sorbitol, and other dietary 
polyols, when substituted for sucrose 
in chewable dietary items, can reduce 
caries (for reviews9-I3). However, no 
studies on sugar alternatives have 
been carried out in subjects with 
exposed root surfaces. The purpose 
of this paper is to report results from 
an exploratory study of the usage of 
xylitol- and sorbitol-containing chew- 
able saliva stimulants (chewing gums 
and dragkes) among patients with 
exposed root surfaces and patients 
receiving periodontal treatment. 
Methods 
This exploratory study was carried 
out at the Veterans Affairs Medical 
Center (VAMC) in Dayton, Ohio. In 
accordance with Veterans Affairs reg- 
ulations, the Dental Service of the 
VAMC must see all resident patients 
and outpatients every six months for 
dental checkups, including treatment 
of possible RSC and periodontal 
infections. The clinical examinations 
of the present study were carried out 
as part of these pre-scheduled, stan- 
dard recalls; the performance of this 
study did not presume extra visits. 
(A) RSC program 
Subjects 
After the approval of the study proto- 
col, the examiner (DP) who per- 
formed the RSC examinations intro- 
duced the program to potential sub- 
jects. Recruiting of subjects continued 
from the spring of 1989 to February, 
1992. The program was introduced to 
all inpatients with exposed root sur- 
faces, upon the patients’ regular vis- 
its to the clinic. The subjects were 
informed about the details of the pro- 
gram, followed by a reading and 
signing of the standard VAMC con- 
sent form; all questions presented by 
the subjects were answered. 
Participation was voluntary. All of 
the VAMC‘s ambulatory, domiciliary 
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Table 1. Baseline characteristics of the subjects in the RSC program. 
Group Sample Mean Age (SD) Mean No. of Active Mean No. of Root Mean No. Drugs 
Size” (years) SGRSC Lesions Surfaces at Risk Used Daily 
at Baseline (SD) at Baseline (SD) to Treat Medical 
Conditions (SD) 
No intervention 105 59.8 (11.2) 1.29 (2.48) 35.8 (21.9) 2.5 (1.5) 
Sorbitol 42 58.6 (10.7) 0.38 (1.03) 35.5 (15.9) 2.8 (1.1) 
Xylitol 41 54.8 (10.3) 1.10 (2.54) 35.6 (22.2) 2.9 (1.4) 
”All non-participating subjects available (105) were included to increase the sample’s representativeness. 
patients with exposed root surfaces 
and with putative cooperativity were 
eligible. Patients who were mentally 
incapacitated, who did not compre- 
hend the purpose of the program, 
and who could not sign the consent 
form were excluded. By February, 
1992, when the last subjects were 
recruited, a total of 220 patients had 
been interviewed. One hundred and 
eighty-eight subjects (later called 
“active subjects”) consented to the 
program, and were systematically 
assigned to xylitol or sorbitol. The 
average number of examinations 
(RSC registrations) after treatment 
assignment (including baseline) was 
4.7 (standard deviation = 1.5). The 
examinations were carried out as part 
of the regular, prescheduled six- 
month recalls of the patients. The 
maximum number of follow-up 
examinations (for a few patients) was 
7. The subjects were followed for 1.8 
years (standard deviation = 0.81) on 
the average. About 60% of the 
patients had used the VAMC dental 
services for more than three years 
before this study. About 30% had 
used these services for fewer than 
three years, while 10% of the patients 
had visited the Dental Service once or 
twice before the study (normally pre- 
suming a six- to 12-month stay at 
VAMC). Table 1 gives other baseline 
characteristics of the samples. 
The VAMC patient base is statisti- 
cally skewed and differs significantly 
from the outpatient population. This 
skew results mostly from the use of 
tobacco, alcohol, and drugs, from 
poor oral hygiene and diabetes, and 
from use of prescribed and other 
medicines. The most common med- 
ications used included antidepres- 
sants, those for hypertension and 
heart problems, and insulin. The 
patients received these medicines in 
the form of pills. The mean number 
of drugs used daily is shown in Table 
1. In general, these subjects did not 
respond well to oral hygiene instruc- 
tions. Flossing and use of other oral 
hygiene procedures were not com- 
mon. Several subjects had periodon- 
tal infections and exposed roots. The 
subjects (including non-participating 
ones; vide inpa) had, on average, 18 
teeth present, of which an average of 
eight had exposed roots at baseline. 
Of those subjects who completed the 
minimum of six months of treatment, 
15 had complete dentures (normally 
in the upper jaw), while 45 had par- 
tial dentures. None of the subjects 
suffered from Sjogren’s syndrome or 
malfunction of the salivary glands 
because of radiation therapy or 
surgery. 
average, two VAMC-made meals a 
day in the dining room. These meals 
were nutritionally balanced. Some 
patients consumed a clinical diet. All 
patients had access to a canteen 
where most had an average of two or 
more meals or snacks daily. The can- 
teen food items were not dietetically 
controlled and represented typical 
foods that contain salt and sugars. 
The mean age of the subjects was 56.6 
years. 
The research protocol approved 
by the governing bodies involved 
(vide infra) presumed a study of xyli- 
to1 stimulants, with the correspond- 
All active resident subjects had, on 
ing sorbitol products regarded as 
active controls (placebos), as has been 
done in some studies. No other place- 
bo-control groups could be formed. 
However, the VAMC resident patient 
population included several individ- 
uals who did not participate in this 
program (either declining or being 
incapacitated to participate). The RSC 
records of some of those patients 
were available. The mean age of these 
non-participating subjects, and their 
racial and gender distribution, 
dietary habits (including visits at the 
canteen), and medical histories were 
more or less similar to those of the 
treated groups. These patients were 
treated at the VAMC exactly as 
patients receiving xylitol or sorbitol 
products. However, no saliva sam- 
ples (vide infra) were collected from 
these patients. The purpose was not 
to regard the non-participating sub- 
jects as a customary control group; 
their inclusion resulted from the 
availability of their SGRSC records 
for comparative purposes. 
Study design 
The consenting subjects were system- 
atically assigned at baseline to xylitol 
or sorbitol (every other patient was 
assigned to the xylitol group, in the 
order the patients visited the Dental 
Service). The groups did not differ 
with regard to oral health dietary 
habits, number and type of medicines 
received, gender, race, age, and other 
relevant characteristcs (such as the 
number of missing teeth, teeth pre- 
sent, the number of teeth with 
exposed roots, and the number of 
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R = Resting 
P = Paraffin 
X = Xylitol 
S = Sorbitol 






Fig 1. Effects of saliva stimulants on salivary flow rates in RSC patients. Ten subjects 
with SGRSC lesions were tested on three consecutive days at 09.00 hours. On day 1, 
two resting saliva samples were collected (after subjects avoided chewing for a period 
of 30 min), one during 0-5 min, another during 5-10 min. On day 2, the subjects 
chewed a piece of paraffin for 5 min. Saliva samples were thereafter collected as 
above, with no stimulus used. On day 3, similar saliva collections were carried out 
after subjects chewed xylitol gum for 5 min. Application of the t test showed the fol- 
lowing: Paraffin and the chewing gums differed significantly as shown [xylitol and sor- 
bitol did not differ significantly; resting saliva flow rates differed from stimulated saliva 
flow rates at the p e 0.001 level (0-5 min) or at the p e 0.05 or p s: 0.01 level (510 
rnin)]. Gums and paraffin were used in this test rather than dragees because gum base 
and paraffin caused similar mechanical stimulations. To make the gums isosweet, 
investigators added aspartame to sorbitol gums. 
SGRSC lesions at baseline). A dental 
assistant who knew the patients per- 
sonally carried out the delivery of the 
saliva stimulants. Normally, a suffi- 
cient quantity of products was given 
to each patient for one-month use. 
The patients were advised to use 
from three to five dragees (polished, 
rounded tablets; vide infra) or one 
stick of gum at a time five times a 
day after main meals and after sug- 
ary snacks. Neither the nursing home 
personnel nor the dental assistant 
made active attempts to check on the 
patients’ actual usage of the stimu- 
lants; volunteerism related to the pro- 
gram was emphasized and main- 
tained. The dental assistant was 
trained and instructed to keep a com- 
pliance diary on each subject. The 
subjects were not aware of this prac- 
tice. The study personnel received 
further information on compliance 
from the resident attendants. 
Experience gained by the study per- 
sonnel suggested that all active sub- 
jects who had consented to the pro- 
gram and who had completed the 
first period (baseline to six months) 
generally complied well during the 
rest of the program. 
The subjects had the opportunity 
to choose between gums and dragees, 
and to change from gum to dragkes 
and vice versa. This was done to 
emphasize volunterism and to 
increase compliance. The estimated 
average daily consumption level of 
xylitol and sorbitol per subject was up 
to 8.5 g (estimated based on the 
quantity of dragees and gums pro- 
vided). Normally, a dragee dose was 
consumed in less than 3 min, while 
subjects chewing gum were instruct- 
ed to chew 15 min. Eighty-five per- 
cent of the subjects in both experi- 
mental groups used predominantly 
dragees. The dragees were polished, 
rounded tablets weighing 0.65 g each, 
and were initially flavored either 
with peppermint, spearmint, cinna- 
mon, or cherry. These flavors were 
used evenly in both experimental 
groups during the initial 3 to 4 weeks 
of the trial; most subjects prefered 
peppermint-flavored products dur- 
ing the rest of the study. The drag6es 
were packed in white, tamper-proof, 
number-coded cardboard boxes 
wrapped with a plastic foil, contain- 
ing about 40 pastilles. The contents of 
one box was normally consumed in 
about two days. The gums were 
stick-shaped and weighed 2.8 g each, 
and were flavored by peppermint. 
Five individually wrapped sticks 
were packed in blank, white, num- 
ber-coded wraps. The dragees and 
the gums were made by the Leaf 
Group of Huhtamaki (Helsinki, 
Finland). The dragees contained 
about 98% of either sorbitol or xylitol, 
the rest including flavor, polishing 
and binding agents, and water. The 
dragees were relatively brittle and 
dissolved easily in saliva, stimulating 
salivation. The gums contained from 
60.5 to 61.2% of either sorbitol or xyli- 
tol, gum base, glycerol, Lycasino, 
lecithin, and flavor.14 The efficacy of 
such gum in stimulating salivation in 
RSC patients is shown in Fig. 1. Even 
five to ten minutes after subjects 
chewed polyol gum, the flow rates 
were significantly higher than those 
measured after they chewed paraffin. 
Similar results were obtained when 
dragees were used as stimulants (not 
shown). The polyol composition of 
random samples of all products was 
monitored throughout the program 
by means of HPLC. The supplies 
were stored at the VAMC in a locked, 
air-conditioned space. 
The subjects and the RSC examin- 
er were unaware of the types of gums 
or dragees used by each individual. 
Periodic checking of the subjects’ and 
the examiner’s awareness of the 
products’ assignments confirmed 
that the effectiveness of the masking 
was not affected, One author (KKM) 
made 18 monitoring site visits at the 
VAMC during the implementation of 
the program. The purpose of the vis- 
its was to verify the correct delivery 
of the clinical suppies, to confirm the 
correct use of the supplies, to meet 
with several subjects and with the 
study personnel, and to ensure the 
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general implementation of the pro- 
gram. An independent monitor 
(Richard C. Brogle Associates, Upper 
Montclair, NJ) was used to assess the 
integrity of the program (4 visits). 
RSC registrations and treatment 
of RSC 
The examining experienced dentist 
(DP) carried out all registrations and 
had the information on active 
supragingival root-surface caries 
(SGRSC) entered by the assistant 
onto standard VAMC patient sheets, 
marking the anatomical location and 
size of the SGRSC lesions on the den- 
tition scheme, using a non-erasable 
red marker. From these VAMC 
forms, the SGRSC information was 
transfered to “statistical” forms for 
data entry into computer. Only active 
SGRSC lesions were included. An 
active RSC lesion was regarded as 
any root-surface area that was well- 
defined, i.e., showed a yellowish or 
light-brownish discoloration, and 
that was softened or leathery upon 
examination with a sharp curette 
applied with moderate pressure. 
Carious tissue could be removed 
from an active RSC lesion by curette. 
Such lesions were frequently covered 
by visible plaque. Inactive lesions 
were found to be impenetrable to a 
sharp caries explorer, but still 
showed the typical discoloration. The 
criteria used in diagnosis correspond- 
ed to those of Fejerskov et a1.15J6 
According to VAMC practice, all 
active SGRSC lesions were restored 
at the regular six-month recalls (indi- 
cating that it was not possible for the 
remineralization of such lesions to be 
studied). If the lesion was very small, 
or if there was doubt about its nature, 
it was not registered as an active 
SGRSC lesion, and it was not 
restored; a red marking was fur- 
nished with a “watch” sign for the 
next examination six months later. 
Such small lesions were, however, 
cleaned, followed by application of 
0.4% SnF,. All deeper lesions were 
also curretted, treated with SnF,, and 
restored with amalgam or light-cured 
glass-ionomer material. The number 
of subjects who received topical fluo- 
ride treatment and fluoride-contain- 
ing restorative materials was estimat- 
ed to be similar in all experimental 
groups. The intraexaminer repro- 
ducibility was tested by the examina- 
tion of a total of 588 exposed root sur- 
faces twice 2 to 3 weeks apart. The 
examiner had good scoring consis- 
tency, with a kappa value of 0.80. The 
purpose of the study was not to 
investigate the conversion of active 
lesions to inactive lesions (”healing 
effect”). The clinical examiner made 
note of such conversion (regarding 
lesions marked with the “watch” 
sign), but, because of their statistical- 
ly smaller number, no further calcu- 
lations on these reactions were made. 
(Although observations of the rem- 
ineralization of such lesions could be 
made, the effects of fluoride applica- 
tion and polyol usage could not be 
differentiated.) 
Statistical treatment of SGRSC 
data 
This study can be regarded as an 
exploratory controlled randomized 
trial. At baseline, the subjects were 
systematically assigned to either sor- 
bitol or xylitol groups. Since system- 
atic assignment and even ”true” ran- 
domization do not necessarily elimi- 
nate all biases, the effects of con- 
founding variables on the treatment 
efficacy estimates were evaluated in 
the analyses. In addition to the treat- 
ment groups, longitudinal data were 
collected for subjects who either 
refused to participate in the trial or 
were unable to participate. This 
group was designated as the non- 
participants’ group. Because only 
about 15% of the subjects used gum, 
it was not justifiable to break down 
the data separately for dragees and 
gums. Furthermore, some subjects 
used both types of saliva stimulants. 
The purpose of the statistical 
analyses was to study the association 
between the rate of new SGRSC and 
type of polyol used.l7J8 During the 
clinical examination, a call was made 
at the tooth level whether the tooth 
had exposed root surfaces (an 
”exposed root surface” was pre- 
sumed to be normal with at least 
about 1 mm recession, depending on 
the location and size of the tooth). If a 
tooth was diagnosed as having no 
exposed root surfaces, no RSC calls 
were made. If a tooth was coded as 
having exposed root surfaces, root 
surfaces could have two possible 
codes: (1) no SGRSC present, imply- 
ing that the root surface was sound 
or had been treated by either planing 
of the affected surfaces until they 
were hard and smooth, or by restora- 
tion; or (2) SGRSC was present. 
Occasionally, a tooth was coded as 
having no recession at one visit, and 
as having recession and SGRSC at the 
next visit. Possibly, such RSC scores 
reflected the discovery of subgingival 
RSC (a SGRSC lesion could also have 
been initially subgingival, becoming 
supragingival after recession, and 
diagnosed as a new SGRSC lesion). 
For each surface, an entry date 
and an exit date were calculated. The 
entry date was the date the surface 
was first at risk for RSC. If a surface 
was exposed at baseline (degree of 
exposure defined above), the entry 
date was the baseline visit date. If a 
surface was non-exposed at baseline, 
but became exposed during the 
study, the entry date was the date 
corresponding to the midpoint19 
between the date the surface was last 
called non-exposed and the date the 
surface was called exposed. The exit 
date was the date of SGRSC onset, or 
the date the surface was last exam- 
ined. Since the exact date of SGRSC 
onset was not known, the exit date 
was the date corresponding to the 
midpoint between the date of the 
visit the surface was last called non- 
carious, and the date of the visit the 
surface was called carious. 
Consequently, for each surface (lin- 
gual, buccal, distal, mesial), three 
outcome variables were available: (1) 
the entry date, (2) the exit date, and 
(3) the RSC call. The explanatory 
variables investigated for each 
patient were: treatment (xylitol, sor- 
bitol, or non-participant), gender, 
subject’s age, and subject’s SGRSC 
experience and risk status at baseline 
( ie . ,  number of surfaces with active 
SGRSC at baseline, and number of 
surfaces with recession at baseline, 
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and number of SGRSC lesions 
restored at baseline). 
Poisson regression models were 
used to relate the onsets of active 
SGRSC to the explanatory variables 
log (yij) = log(T..) + a + X (iJSXKs), ‘I where a is the intercept and d, the 
slope coefficient associated with the 
explanatory variable Xijs.zo 
Exponentiating B (eDs) provides an 
estimate of the rate ratio, and 
explains on a multiplicative scale 
how the root-surface caries reference 
rate varies as a function of the 
explanatory variable. Generalized 
estimating equationsz1 were used to 
estimate the model’s parameters. 
Generalized estimating equations are 
an extension of the multiple regres- 
sion model to a class of maximum 
likelhood procedures.zz The statisti- 
cal significance of each parameter 
was assessed by means of the Wald 
statistics. 
Measurements of saliva 
The use of two available test kits to 
monitor microbiologic changes of 
whole saliva samples of all active 
RSC patients using xylitol or sorbitol 
was studied. For this purpose, all 
active subjects were tested at the end 
of each visit for salivary mutans 
streptococci (which involves one- 
minute chewing of paraffin; the sali- 
va so formed was swallowed), fol- 
lowed by a separate collection of a 
five-minute paraffin-stimulated sam- 
ple of whole saliva. An aliquot of this 
sample was used for a test of lacto- 
bacilli. These tests were carried out 
by means of the Orion Dentocult@ SM 
and LB test kits, respectively (Orion, 
Espoo, Finland); literature on these 
procedures is available upon request. 
The rest of each saliva sample was 
stored at -20°C until analyzed within 
6 to 8 weeks for IgA (by Kallestad’s 
Low Level IgA Endoplate as instruct- 
ed by the test kit insert and 
Kallestad’s Technical Bulletin; Sanofi 
Diagnostics, Chaska, MN), lysozyme 
(with the Calzyme Laboratories 
Micrococcus lysodeicticus lysed cells 
used according to the supplier’s 
instructions), per~xidase?~ 
SCN-F5 and sucrase (the 
reducing sugars were determined by 
the neocuproine [2,9-dimethyl-l,lO- 
phenantroline; Sigma] methodz7), and 
protease activity with Azocoll as sub- 
strate.z8 The rationales of using these 
tests have been explained earlier.z9 
Questionnaire presentations 
Questionnaire forms were presented 
on one occasion (spring, 1991) to 
those “treated” patients (75%) who 
consented to an interview. This ques- 
tionnaire focused on the patient’s use 
of the VAMC dining hall, the can- 
teen, the types of sweet items used 
and the frequency of their use, as 
well as smoking habits and practice 
of oral hygiene. The groups did not 
differ with regard to these properties. 
(B) Periodontal program 
The periodontal portion of the study 
utilized periodontal outpatients of 
the VAMC. The staff periodontolo- 
gist UC) recruited the subjects to the 
program and examined and treated 
them at all subsequent clinical exami- 
nations. The examiner was not aware 
of the grouping of the subjects. By 
February, 1992, a total of 150 patients 
had been interviewed. One hundred 
and twenty-five subjects consented. 
Of these, 25 discontinued their partici- 
pation before the end of the first six- 
month period. Of the 100 remaining 
subjects, 57 were seen in at least two 
successive examinations, 52 were 
seen in at least three examinations, 37 
were seen in at least four examina- 
tions, while 30 were seen in at least 
five examinations (corresponding to 
the 24-month “treatment”). The num- 
ber of patients who were seen at least 
six times (corresponding to 30-month 
usage of saliva stimulants) is also 
given (n = 15) but was considered too 
low for further consideration. The 
distribution of the subjects in the sor- 
bitol and xylitol groups remained 
similar during the study. These sub- 
jects constituted a patient sample that 
was not as skewed statistically as the 
domiciliary patients but that still dis- 
played considerable heterogeneity. 
None of these subjects had Sjogren’s 
syndrome or other malfunction of the 
salivary glands owing to radiation 
therapy or surgery. About 50% of 
these subjects had used the VAMC 
outpatient periodontal services 
longer than three years. The subjects 
were examined every six months at 
their regularly scheduled visits to the 
Periodontal Unit. 
No sialochemical tests were per- 
formed on the periodontal subjects. 
However, the plaque index and gin- 
gival index scores were measured at 
each ~ i s i t . ~ ~ , ~ ’  A microbiologic study 
on the plaque levels of several sus- 
pected period onto pathogen^^^ was 
also conducted by means of a ”slot 
immunoblot” pr~cedure .~~.  A curette 
was used to collect a subgingival 
plaque sample of about 2 mg (fresh 
weight) from the buccal surface of 
one posterior tooth on the right side 
and of one posterior tooth from the 
left side. The samples were taken 
from a diseased site with the highest 
pocket depth present, and were 
obtained from either mandibular or 
maxillary tooth surfaces which did 
not show any signs of RSC. The sam- 
ples were immediately suspended in 
0.5 mL of 1.0% formaldehyde in 1.5- 
mL cryovials. The mixtures were 
stored well-capped at +4”C until 
studied for the presence of micro- 
organisms shown in Table 3. 
The study design presumed the 
comparison of saliva stimulants con- 
taining either xylitol or sorbitol as the 
bulk sweetener, with the latter polyol 
regarded as a placebo. The limited 
patient base did not allow for the for- 
mation of an untreated control group 
of periodontal subjects. Accordingly, 
each subject’s gingival status during 
polyol usage was compared with the 
same subject’s baseline values. At the 
end of the program in 1992,30 sub- 
jects could be recruited for a compari- 
son study of six months’ duration, 
involving the measurement of plaque 
index and gingival index scores at 
three-month intervals. These outpa- 
tients were similar to ”treated” sub- 
jects with regard to all relevant mea- 
sures (age, gender, oral and general 
health, dietary habits), and they were 
subjected to the same standard six- 
month recalls of the VAMC system as 
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Table 2. Changes from baseline to end point of treatment in the rate of SGRSC and in the relative risk (rate ratio, RR) estimatesa in 
the RSC program. 
Group Adjusted for the Following Variables: 
Age Gender No.of No. of 
Crude Incidence Rate 95% SGRSC Lesions SGRSC-free 
Rate of SGRSCb Ratio Confidence Interval at Baseline Surfaces at 
Baseline 
~ _ _ _ _ _ _ _ _  ~~ ~ ~ 
Sorbitol (n = 42) 13.7 (5.9-31.8) 
Xylitol (n = 41) 2.6 (1.1-6.1) 0.19 0.06-0.62 (I' < 0.0065) 
0.20 0.06-0.61 (I' I 0.0051) X 
0.20 0.06-0.61 (P I0.0051) X X 
0.21 0.07-0.62 (I' 5 0.0049) X X X 
0.19 0.06-0.66 (P < 0.0085) X X X X 
~ -~ ~ ~~~~~~~~~~ 
a Means and RR are presented as crude values and also as values adjusted for age; for age and gender; for age, gender, and the num- 
ber of SGRSC lesions at baseline; and for age, gender, and number of SGRSC lesions and recession at baseline (the P values were cal- 
culated separately for the adjustments indicated). The RR values, because they are smaller than l, indicate a decreased risk of 
SGRSC with xylitol us. sorbitol, a beneficial effect. The percent confidence interval expresses the 95% probability that reported inter- 
vals include the true relative risk. The RR (percent confidence interval) statistic is used as a measure of treatment e f f i ~ a c y . ' ~ , ~ ~  
bSGRSC lesion onsets per 1000 surfaces per year (95% confidence intervals). 
the active participants. 
Results 
(A) RSC Program-Baseline 
characteristics 
The total sample size was 188 
patients, with 105 subjects in the non- 
participating group, and about 40 in 
each treatment group (Table 1). The 
distributions of the following vari- 
ables were compared at baseline: age, 
gender, average number of root sur- 
faces with a SGRSC lesion at baseline, 
and average number of root surfaces 
with recession per patient. There were 
no significant differences between the 
xylitol group and the sorbitol group 
at baseline, although the number of 
active SGRSC lesions at baseline was 
smaller in the sorbitol group than in 
other groups. Subjects in the sorbitol 
group were, on average, five years 
younger than those in the non-partic- 
ipants' group (95% CI, 0.19 to 0.83). 
The difference in age between these 
two groups was responsible for a sig- 
nificant heterogeneity in age distribu- 
tion across the compared groups 
(one-way analysis of variance, p 5 
0.045). Patients in the treatment 
groups also had more SGRSC lesions 
than those in the non-participants' 
group (95% CI, 0.10 to 1.73). This dif- 
ference in the number of SGRSC 
lesions between the two groups was 
not sufficient to cause a significant 
overall heterogeneity in SGRSC dis- 
tribution across the compared 
groups. The number of exposed root 
surfaces was approximately 36 for all 
groups. About 10% of the sample 
consisted of female subjects, and 
there were no significant differences 
in the proportion of females among 
the compared groups (chi-square 
with two degrees of freedom, p I 
0.443). 
RSC Program-Effectiveness of 
SGRSC treatments 
In the sorbitol group, there were 36 
SGRSC surfaces and a total root-sur- 
face time at risk of 2632 years, lead- 
ing to a SGRSC rate of 13.7 onsets per 
1000 surfaces per year (95% confi- 
dence intervals: 5.9 to 31.8; Table 2). 
In the xylitol group, there were six 
SGRSC onsets and a total root-surface 
time at risk of 2349 years, leading to a 
SGRSC rate of 2.6 onsets per 1000 sur- 
faces per year. A ratio of the caries 
rates in the two groups leads to an 
estimate of the relative risk of 0.19 
(95% confidence intervals: 0.06 to 
0.62; p 5 0.0065). Adjustment of the 
relative risk estimate for potential 
confounding factors did not appre- 
ciably change these conclusions 
(Table 2). Only the comparison 
between sorbitol and xylitol is 
shown, since a comparison with the 
non-participating group was not con- 
sidered justified. The crude SGRSC 
rate calculated for this group (n = 
105) was 33.6 per 1000 surfaces per 
year (95% confidence intervals: 26.7 
to 42.3). 
RSC Program-Ancillary studies 
The whole-saliva samples obtained 
from RSC patients did not differ sig- 
nificantly between polyol-using 
groups with regard to the levels of 
protein, SCN-, amylase, sucrase, 
protease, peroxidase, lysozyme, and 
IgA. The salivary flow rates did not 
differ. When the baseline values were 
compared with values determined 
during "treatments" in each group, 
no consistent and significant differ- 
ences were observed. No chemical or 
biologic studies were conducted on 
non-participating patients. 
salivary mutans streptococci evalu- 
The Orion Diagnostica test kit for 
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Fig 2. Mean plaque index scores (2 SD; number of patients studied at each examina- 
tion is indicated) of the VAMC periodontal outpatients who received xylitol- or sorbitol- 
containing saliva stimulants for periods of six to 30 months. Similar plaque index mea- 
surements were carried out at 27-33 months in non-participating subjects who did not 
receive the above saliva stimulants. The 24-month values in both polyol groups differed 
significantly (p c 0.05; ANOVA) from the two last (30- and 33-month) non-participants’ 
values. 
ates the presence of these organisms 
by means of a score system (zero, 1, 
2, and 3). The mean scores at baseline 
were 1.32 + 0.90 for the sorbitol 
group and 1.16 k 0.91 for the xylitol 
group, respectively (not shown). 
These means did not differ signifi- 
cantly. After 24 months, the mean 
score had been reduced by 30% in the 
sorbitol group and by 57% in the xyli- 
to1 group. At 24 months, 74% of the 
sorbitol group subjects and 94% of 
the xylitol-using subjects had a low 
score (i.e., zero or one). The number 
of subjects with low scores was sig- 
nificantly (p < 0.05) higher in the xyli- 
to1 group, but not in the sorbitol 
group. These trends were visible also 
at the six-, 12-, and 18-month exami- 
nations, but not as clearly as at 24 
months. The number of whole-saliva 
samples was not sufficient for these 
tests at 30 months. The mean log,, 
counts of salivary lactobacilli at base- 
line were 3.75 in the sorbitol group 
and 3.21 in the xylitol group. The 
log,, counts remained essentially 
unchanged in the sorbitol group dur- 
ing 24 months, while in the xylitol 
group the 18- and 24-month mean 
log,, counts were 2.44 and 2.64, 
respectively, the 18-month counts dif- 
fering significantly between sorbitol 
and xylitol (p < 0.001), the difference 
in the 24-month counts approaching 
significance (p = 0.07) (not shown). 
These bacteriologic results (obtained 
with commercial test kits) did not 
change if alternative procedures 
(such as calculating the percentage of 
low and high scores) were used, 
instead of the mean scores calculated. 
(6) Periodontal program 
The Silness-Loe plaque index scores 
showed a reducing but not signifi- 
cant trend during the study in both 
experimental groups (Fig. 2). The 
mean scores determined for the non- 
participating group patients were 
similar to those measured at baseline 
for the polyol-using subjects. The 
mean gingival index scores reduced 
significantly during “treatment” in 
both polyol groups (Fig. 3). The 
scores measured for the non-partici- 
pating subjects were not significantly 
different from those determined at 
baseline for the polyol-using patients. 
The polyol-receiving subjects pro- 
vided plaque samples which were 
studied for the presence of the fol- 
lowing organisms: Streptococcus 
mutans, S. sanguis, Prevotella interme- 
dia, Porphyromonas gingivalis, 
Actinobacillus, Treponema den ticola, 
Actinomyces viscosus, Fusobacterium 
nucleatum, Bacillus forsythus, and 
Selenomona sputigena (Table 3). The 
results suggest that the usage of both 
saliva stimulants was associated with 
some shifts in the mean index scores 
of these organisms compared with 
baseline. The plaque levels of S. 
mutans showed some period effects 
for up to 24 months when the num- 
ber of diseased sites sampled was 
still relatively high. More consistent 
shifts were observed, however, in the 
plaque levels of Actinobacillus and T. 
denticola, which increased toward the 
end of the program. The levels of S. 
sputigena showed, in turn, decreasing 
scores at 24 and 30 months. The pre- 
liminary nature of these findings 
must be emphasized. The values 
shown for the 6th visit (at 30 months) 
should be viewed against the lower 
number of diseased sampling sites 
available at this examination, i.e., 25 
sites in the sorbitol group and 21 sites 
in the xylitol group (Table 3). 
Discussion 
The results suggest that habitual con- 
sumption of xylitol-containing saliva 
stimulants can be associated with a 
significantly decreased root caries 
risk when compared with sorbitol 
usage. There are several viewpoints, 
however, that should be considered 
in evaluation of the effects of xylitol 
and sorbitol on the prevention of 
SGRSC in this study. The number of 
subjects available for the study was 
relatively small. The “treatment” 
time was relatively short in several 
patients. The study design had to 
acknowledge the right of the subjects 
to choose between chewing gums 
and dragbes; the subjects could 
switch from gums to dragbes and vice 
versa. Although this did not happen 
frequently, this study did not demon- 
strate which form-the gum or the 
dragke-is most effective. The study 
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lacked a true control group. It is pos- 
sible that the recruiting process per- 
suaded only the most alert and 
health-conscious patients to consent 
to the program, excluding several 
RSC-prone individuals who were 
perhaps typically included in the 
non-participating group. It would 
have been useful to determine the 
degree of gingival recession in all 
RSC patients, and, conversely, the 
gingival recession data of the perio- 
dontal subjects should have been 
compared with the incidence of RSC 
in these subjects (the RSC and the 
periodontal programs utilized differ- 
ent patient samples, and were sepa- 
rate because of administrative and 
practical reasons). RSC indices, diag- 
nostic criteria, and clinical signs of 
RSC have been d i s c ~ s s e d . ~ ~ , ~ ~ , ~ ~  The 
measurement of RSC indices could 
not be performed, whereas the diag- 
nostic criteria used can be regarded 
as comparable with those used by 
other researchers. It can also be 
argued that the allocation of patients 
to the polyol groups was not truly 
random and that some subjects 
showed improvement in periodontal 
health owing to the semi-annual 
recalls rather than the usage of saliva 
stimulants. The semi-annual recalls 
of the VAMC were routine, however, 
and the present subjects and the par- 
ticipating periodontist were accus- 
tomed to this procedure. 
present SGRSC rates with those cal- 
culated for pre-baseline years. 
Records collections at the VA system 
allowed for this calculation for a 
number of subjects for periods of six 
to 24 months prior to baseline. These 
SGRSC rates were as follows: non- 
participating group, 40.33 (95% confi- 
dence interval, 26.56-61.25; n = 84); 
sorbitol group, 18.36 (10.40-32.40; n = 
20); and xylitol group, 14.07 (5.90- 
33.52; n = 22). Although these pre- 
baseline data were incomplete, they 
suggest that the non-participating 
group was more susceptible (p < 
0.05) to SGRSC than the polyol 
groups. It is thus likely that more 
compliant, cooperative, and health- 
conscious patients volunteered in the 
program. 
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Fig 3. Mean gingival index scores (i SD; number of patients studied at each examlnb 
tion is indicated) of the VAMC periodontal outpatients who received xylitol- or sorbitol- 
containing saliva stimulants for periods of six to 30 months. Similar ginglval Index 
measurements were carried out at 27-33 months in non-participating subjects who did 
not receive the above saliva stimulants. The 18- and 24month values, in both polyol 
groups, differed significantly (p c 0.05; ANOVA) from the baseline and non-partici- 
pants' values. 
This study was the first ever to 
investigate the effect of the usage of 
polyol-containing saliva stimulants in 
Veterans Affairs patients. The practi- 
cal implementation of this type of a 
program on a VAMC campus is gen- 
uinely affected by the nature of the 
subjects and by local circumstances. 
Several patients showed little or no 
interest in oral health. Maintaining 
the program even with the present 
number of subjects was considered a 
substantial achievement. The best- 
cooperating subjects were often dis- 
missed from the hospital during the 
program owing to their improved 
health status. Such incidents weak- 
ened the subject base of the study 
and contributed to the higher 
dropout rate. Superimposed on this 
study was an attempt to modify 
health behavior. Changing health 
behavior can be difficult when a 
change-resistant study group is 
involved. The experience gathered in 
this study showed that any attempt 
to alter Veterans Affairs patients' oral 
health by means of this type of pro- 
gram will confront formidable diffi- 
culties and presumes special motiva- 
tion of the health care personnel 
involved. On the other hand, even 
minor achievements may be consid- 
ered valuable and should prompt 
more full-scale studies. It is possible, 
of course, that the present attempts to 
modify health behavior may have 
affected the observed RSC outcome. 
Such effects should be carefully con- 
sidered in future full-scale studies of 
RSC in VAMC patients. However, 
both the sorbitol (placebo) and the 
xylitol group subjects were treated 
similarly in this study, and the same 
basic treatment (including the use of 
fluoride-containing materials), pro- 
phylaxis, and instructions were given 
to all subjects, including the non-par- 
ticipating patients. The subjects and 
the resident attendants did not report 
any adverse effects from the usage of 
the present polyol products. 
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Table 3. Mean index scores of ten microorganisms present in the subgingival dental plaque of the VAMC periodontal outpatients who 
received sorbitoi- or xylitoicontaining saliva stimulants over a period of SIX to 30 months. The plaque was collected from periodontal- 
ly diseased sites without RSC. 
Time in Months 
Organism Baseline 6 12 18 24 30 




































0.96 f 0.94 
0.97 * 0.97 
1.71f 1.00 
1.64 f 1.05 
1.62 f 0.97 
1.58 + 0.96 
1.06 f 0.87 
1.10 f 0.99 
1.19 f 0.91 
0.97 f 0.98 
1.40 f 1.00 
1.28 f 1.06 
2.17 f 0.98 
1.98 f 1.02 
1.32 f 0.86 
1.31 f 1.00 
1.57 f 1.08 
1.39 f 1.11 
1.53 f 1.10 
1.52 f 1.09 
55 
55 
1.22 + 0.94” 
1.09 + 1.02” 
1.94 f 1.03 
1.80 + 1.13” 
1.74 f 0.93 
1.73 f 0.99” 
1.47 + 0.92b 
1.38 f l . O l b  
1.36 f 0.97 
1.14 f 1.03 
1.44 f 0.92 
1.34 f 1.00 
2.25 f 0.86 
2.05 + 0.95 
1.34 f 0.93 
1.27 f 0.99 
1.67 f 0.98 
1.44 f 1.19 
1.82 f 1.02 
1.58 f 1.07 
47 
53 
1.43 + 1.16b 
1.07 1.05 
1.81 f 1.12 
1.62 f 1.02 
1.64 f 1.03 
1.75 * 1.05” 
1.49 & 1 .08b 
1.38 F 1.04b 
1.60 ? l . l O b  
1.26 f 1.11 
1.47 f 1.12 
1.21 f 1.03 
2.15 -c 1.00 
1.92 -t 0.97 
1.40 * 1.11 
1.26 * 0.96 
1.55 * 1.16 
1.49 f 1.19 
1.66 t 1.18 




1.20 f 0.98 
1.18 f 1.05b 
1.79 f 0.98 
1.51 f 1.08 
1.77 f 1.13 
1.71 f 1.10” 
1.38 f 0.99b 
1.49 f 0.97b 
1.61 f 0.96b 
1.49 f 0.99b 
1.49 f 1.07 
1.40 f 1.07 
1.97 f 1.06 
2.04 f 0.91 
1.54 + 1.00 
1.40 + 1.01 
1.72 f 1.00” 
1.53 + 0.94b 
1.61 f 1.02 
1.31 f 1.10 
30 
41 
1.33 f 0.99b 
1.19 f 1.14b 
1.73 f 1.11 
1.56 f 1.05 
1.73 f 1.01 
1.63 + 1.02 
1.40 f 1.10” 
1.49 f 1 .OOb 
1.87 f l . O l b  
1.61 f l .OOb 
1.17 f 0.91 
1.17 f 1.12 
2.17 f 0.95 
2.02 f 0.91 
1.77 + 0.90b 
1.49 f 1.03 
1.43 f 0.86 
1.49 f 1.03 
1.03 f 1.13” 
0.98 f 1.08” 
25 
21 
1.19 * 1.29 
1.00 f 1.15 
1.32 f 1.14” 
1.33 f 1.11 
1.28 f 1.06 
1.62 + 1.16 
1.16 f 1.07 
1.67 f l.OSb 
1.52 f 1.16” 
1.67 f 1.06b 
1.24 f 1.16 
1.24 f 1.22 
1.92 f 1.11 
2.14 f 0.85 
1.40 f 1.04 
1.57 f 1.12 
1.44 f 1.08 
1.43 f 1.16 
0.80 f 1.04” 
1.19 f 1.17 
Two plaque samples were obtained from most patients, one sample from the buccal surface of one posterior tooth on the right side, 
the other from the left side. In this proced~re?~ scores of 0, 1,2, or 3 are given to samples depending on the amount of organisms 
present in the sample (only those samples were included which contained a sufficiently high level of carbohydrates, as described 
e l~ewhere~~) .  
a The difference from baseline approached significance (i.e., 0.05 < p < 0.10). 
The difference from baseline was significant (p < 0.05). 
In spite of the shortcomings and 
difficulties indicated above, the study 
results were in overall agreement 
with previous findings regarding the 
relationship between xylitol con- 
sumption and caries prevention, 
plaque growth, presence of mutans 
streptococci in whole saliva, and sug- 
gestions about the indirect, ”inflam- 
mation-dampening effect” 
( r e ~ i e w e d ~ ~ )  of xylitol usage. In the 
present study, most of these effects 
were also achieved by means of the 
usage of sorbitol-containing saliva 
stimulants. Although no previous 
study has investigated the relation- 
ship between consumption of polyol- 
containing saliva stimulants and 
SGRSC, there is information on the 
relationship between polyol usage 
and coronal caries in adults and juve- 
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nile subjects. According to this infor- 
mation (reviewed9-I3), the consump- 
tion of xylitol has been more effective 
than that of sorbitol as a caries-redu- 
cing agent. Although RSC and coro- 
nal caries, and caries that affects the 
primary dentition, may be regarded 
as partly separate diseases, the pre- 
sent results and previous literature 
suggest that it may also be possible to 
affect RSC-and perhaps dental 
caries in its entirety-by means of 
programs involving systematic usage 
of essentially nonfermentable saliva 
stimulants, 
The conversion of active RSC 
lesions into inactive ones by 
improved oral hygiene has been 
reported.15 It was also shown, in a 
randomized cross-over study, that 
demineralization of RSC lesions was 
increased by 83.5% in the "baseline 
group", compared with only 0.9% in 
the group that used sugarless gum.37 
In that study, artificial caries lesions 
were created in root sections which 
were placed into proximal prepara- 
tions in molar teeth. Subjects were 
then given sugar candy for three 
weeks, after which the root sections 
were e ~ a m i n e d . ~ ~ , ~ ~  Although the 
present study did not expressly 
investigate the conversion of active 
lesions into inactive ones, these find- 
ings nevertheless support the above 
results and suggest that polyol-con- 
taining saliva stimulants may actual- 
ly prevent the formation of new 
SGRSC lesions. Although old age 
may not significantly affect an indi- 
vidual's ability to secrete IgA into 
saliva, or the salivary flow rate and 
the protein concentration of saliva?9 
it has been reported that the opsonic 
activity (important in microbicidal 
activity) of saliva can be adversely 
affected with age.8 The use of an 
essentially nonfermentable saliva 
stimulant (xylitol) may therefore be 
of additional value in the planning of 
preventive strategies for VAMC 
patients. An unexpected and favor- 
able outcome was several smoking 
patients' reduced craving for ciga- 
rettes as a result of habitual usage of 
the present saliva stimulants (not 
shown). This is clearly an area where 
more research should be conducted. 
Previous literature has shown that 
xylitol usage reduces the growth of 
dental plaque more effectively than 
sorbitol usage ( r e~ iewed~~) ,  and that 
xylitol reduces the growth of mutans 
streptococci, while sorbitol normally 
supports their growth. Whether this 
metabolic feature explains the report- 
ed effectiveness of xylitol as a caries- 
reducing agent, compared with sor- 
bitol, remains outside the scope of 
this discussion, but it is a defensible 
explanation. However, usage of sor- 
bitol-containing saliva stimulants did 
have a SGRSC-limiting effect. 
Therefore, it is possible that the 
effects of both stimulants on SGRSC 
also involve salivary effects. The 
mere lower fermentation rate of sor- 
bitol and the virtually nonfermenta- 
tive nature of xylitol in most dental 
plaque material, compared with 
sucrose, also contribute to the net 
effect. 
Previous studies suggest that 
there is a positive correlation 
between the presence of active RSC 
and increased plaque levels of 
mutans streptococci and lactobacil- 
li.40-42 Plaque and saliva levels of 
mutans streptococci do not always 
respond to treatments in the same 
way. The occasional increases in the 
plaque levels of mutans streptococci 
observed in periodontal patients 
(Table 3) do not, therefore, necessari- 
ly contradict the decrease observed in 
salivary levels of mutans streptococci 
in RSC patients; in studies involving 
xylitol usage, it is the salivary levels 
that are more significantly and con- 
sistently reduced. Furthermore, the 
plaque samples for the periodontal 
study were not obtained from RSC 
lesions. Organisms other than 
mutans streptococci and lactobacilli, 
however, are also important to dental 
health. 
Several reports have suggested 
that the usage of xylitol is associated 
with effects that can lead to less 
inflamed gingivae ("inflammation- 
dampening effect"; review36). It is 
possible that xylitol and sorbitol do 
not differ in their effects on gingival 
and periodontal health, although 
there are less-than-adequate data 
from long-term trials. Short-term gin- 
givitis studies have yielded similar 
results with these p01yols.~~ No 
known periodontopathogen uses xy- 
litol as a preferred substrate (shifts in 
the relative amounts of periodontal 
bacteria may still occur, as shown in 
Table 3) .  Xylitol inhibited several 
period onto pathogen^^^ and reduced 
the adhesiveness of dental plaque 
(microbial adhesiveness may con- 
tribute to periodontal disease).44 
Studies in experimental animals 
showed that xylitol plaque obtained 
from xylitol-consuming human sub- 
jects was less inflammatory than 
samples of sucrose or fructose 
plaque.45 Bone culture s t ~ d i e s ~ ~ , ~ ~  
support this concept; xylitol plaque 
was less irritating to macrophages 
and bones than sucrose plaque. 
Xylitol mouthrinses were periodon- 
tally less harmful than sucrose 
 rinse^.^^,^^ Gingival bleeding was 
reduced in juvenile subjects who con- 
sumed xylitol s a l i~a - s t imu lan t s~~~~~  
It is possible that the strongly 
improved gingival health of the 
periodontal patients was associated 
with such phenomena. 
This study showed that the slot- 
immunoblot procedure33 can be used 
in this type of long-term clinical pro- 
gram to monitor the presence of perio- 
dontal-disease-associated organisms 
(risk markers) in subgingival dental 
plaque. The results indicate that 
while most of the organisms tested 
showed few or no consistent changes, 
the plaque levels of two organisms 
(Actinobacillus, T. denticola and possi- 
bly S. sputigena) tended to change 
more consistently and significantly in 
"treated" subjects, with both polyols 
exhibiting a similar effect. This obser- 
vation may be related to that of 
Rateitschak-Pluss and Guggenheim?* 
who found a statistically significant 
increase in the proportions of anaero- 
bic sorbitol- and xylitol-fermenting 
bacteria in the dental plaque of sor- 
bitol- and xylitol-consuming subjects 
during a four-day test period. The 
present immunoblot procedure does 
not, however, differentiate between 
virulent and nonvirulent strains. It is 
possible that the shifts in the levels of 
these organisms concerned only non- 
virulent strains, although this matter 
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must be investigated separately. The 
importance of various bacterial 
species found in subgingival plaque 
of periodontitis patients is still sub- 
ject to debate. Habitual polyol usage 
may affect the ratios of periodontal 
organisms in the same way as it 
affects the levels of mutans strepto- 
cocci and lactobacilli in some studies. 
Conclusions 
(1) The oral health status appeared to 
be favorably affected by the usage of 
polyol-containing saliva stimulants. 
(2) The xylitol-containing saliva 
stimulants was more effective in pre- 
venting active SGRSC than were sor- 
bitol-containing stimulants. 
(3) Both polyols appeared to have 
a similar effect on periodontal health. 
The microbial shifts that may occur 
during habitual polyol consumption 
(in terms of elevated levels of 
Actinobacillus and T. denticola in sub- 
gingival plaque) should be evaluated 
in more detailed studies. 
(4) The patient population of the 
VAMC offered considerable chal- 
lenges. Considering the difficulties 
generally encountered in instructing 
VAMC patients with regard to better 
health habits, any favorable changes 
in health behavior in such patients- 
even those changes reported above- 
should be considered encouraging 
and should prompt further research. 
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